Blog
RSS FeedPosted by Michael Wonder on 22 Nov 2019
Corbyn pledges to create state-run generics firm to cut drug prices
22 November 2019 - Labour leader Jeremy Corbyn has included in the party’s election manifesto plans to create a state-run ...
Posted by Michael Wonder on 13 May 2019
The UK’s new medicines pricing deal – opportunities and risks for pharma
10 May 2019 - January 2019 saw the introduction of the new Voluntary Scheme for Branded Medicines Pricing and Access ...
Posted by Michael Wonder on 25 Mar 2019
Pharma fears “lack of focus” on no-deal Brexit preparations
22 March 2019 - As Brexit is delayed, pharma suggests new measures to avoid no-deal drugs shortages. ...
Posted by Michael Wonder on 06 Mar 2019
Firm in NHS row over cystic fibrosis drug paid almost no UK tax
6 March 2019 - European division of Vertex made loss while paying large sum to profitable US owner. ...
Posted by Michael Wonder on 27 Feb 2019
Pharma industry swamped with no-deal Brexit info, says BIA
27 February 2019 - Deluge comes just as prime minister hints at delay. ...
Posted by Michael Wonder on 23 Feb 2019
Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model in a pharmaceutical company
21 February 2019 - Evidence requirements and assessment methods access differ between health technology assessment agencies. ...
Posted by Michael Wonder on 16 Jan 2019
The UK’s new five year pricing agreement
16 January 2019 - Pharma has agreed to capped growth again – in exchange for uptake promises. ...
Posted by Michael Wonder on 10 Dec 2018
Pharma calls for more detail on plan for post Brexit medicines access
10 December 2018 - The pharmaceutical industry is calling on the government to urgently provide more detail on how it ...
Posted by Michael Wonder on 05 Dec 2018
NHS to save £1 billion on its medicines bill in 2019
5 December 2018 - The NHS is expected to save around £930 million on its medicines bill across the UK ...
Posted by Michael Wonder on 27 Nov 2018
Pharma agrees to 2 percent cap on branded meds growth
25 November 2018 - The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price ...
Posted by Michael Wonder on 26 Nov 2018
UK pharma industry reacts to outcome of European Council meeting
25 November 2018 - The European Council has endorsed the Agreement on the withdrawal of the UK from the EU and ...
Posted by Michael Wonder on 19 Nov 2018
Pharma ignores the squabbling and prepares for a hard Brexit
19 November 2018 - Costs are irrecoverable in industry that has to plan for all possible scenarios. ...
Posted by Michael Wonder on 17 Nov 2018
BHA, ABPI welcome UK’s EU withdrawal agreement
16 November 2018 - The Brexit Health Alliance has welcomed the agreement on the terms of the UK’s withdrawal from ...
Posted by Michael Wonder on 11 Oct 2018
ABPI tells MPs Brexit deal on medicines regulation ‘urgently needed’
11 October 2018 - Pharmaceutical companies “are doing everything in their power” to minimise disruption to the supply of medicines ...
Posted by Michael Wonder on 14 Sep 2018
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
14 September 2018 - The UK could be “less interesting” to pharma and life sciences firms after Brexit, the CEO ...